Clinics and research in hepatology and gastroenterology, vol.42, no.1, pp.40-47, 2018 (Journal Indexed in SCI Expanded)
Article / Article
Title of Journal :
Clinics and research in hepatology and gastroenterology
Background: Entecavir (ETV) and tenofovir disoproxil fumarat (TDF) are the two first-line therapies recommended in the treatment of chronic hepatitis B because of having potent antiviral effect and high genetic barriers against resistance. We aimed to compare efficacy of these drugs and to evaluate predictors of viral suppression.